ClinicalTrials.Veeva

Menu

The Effect of Tranexamic Acid on Postpartum Hemorrhage During and After Cesarean Delivery

T

Tehran University of Medical Sciences

Status and phase

Completed
Phase 2
Phase 1

Conditions

Hemorrhage

Treatments

Drug: Normal saline
Drug: Tranexamic acid

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

Intravenous Tranexamic acid is used to reduce the hemorrhage during and after cesarean delivery in a double blind randomized placebo controlled trial.

Enrollment

100 patients

Sex

Female

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  1. Term pregnancy
  2. Single fetus
  3. Maximally only one previous cesarean delivery

Exclusion criteria

  1. More than one previous cesarean delivery
  2. Hx of other abdominal or pelvic surgery
  3. Hx of medical disorders
  4. Hx of thromboembolic disorders
  5. Polyhydramnios
  6. Macrosomia
  7. Preeclampsia
  8. Hx of sensitivity to Tranexamic acid
  9. Abnormal Pt, PTT, PT or INR

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Quadruple Blind

100 participants in 2 patient groups, including a placebo group

Tranexamic acid
Experimental group
Treatment:
Drug: Tranexamic acid
normal saline infusion
Placebo Comparator group
Treatment:
Drug: Normal saline

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems